The text discusses a longitudinal study on chronic allograft nephropathy in kidney transplant recipients, particularly focusing on the natural history and pathophysiology of the condition. The study involved 120 patients who underwent kidney transplant biopsies over a 10-year period. The findings revealed two distinct phases of injury post-transplantation: early tubulointerstitial damage related to immunologic factors and later damage associated with calcineurin-inhibitor nephrotoxicity. The study highlights the prevalence and impact of calcineurin-inhibitor nephrotoxicity on long-term graft survival, suggesting that these agents may contribute significantly to chronic allograft nephropathy. The text proposes a two-stage treatment approach, utilizing potent calcineurin inhibitors initially to minimize immunologic injury, followed by non-nephrotoxic immunosuppression for long-term maintenance. The study emphasizes the need for further research and controlled trials to optimize treatment strategies and prevent chronic allograft nephropathy in kidney transplant recipients.